Continental Investors Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Continental Investors Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$355K	Buy	2,318 +2	+0.1%	+$270	0.28%	58
2026 Q1	$312K	Hold	2,316	–	–	0.29%	63
2025 Q4	$289K	Sell	2,316 -23	-1%	-$2.64K	0.37%	60
2025 Q3	$252K	Buy	+2,339	New	+$211K	0.37%	61
2025 Q1	–	Sell	-2,339	Closed	-$211K	–	65
2024 Q4	$211K	Buy	2,339 +1	+0%	+$97	0.42%	59
2024 Q3	$229K	Hold	2,338	–	–	0.47%	56
2024 Q2	$217K	Buy	2,338 +3	+0.1%	+$269	0.48%	58
2024 Q1	$219K	Hold	2,335	–	–	0.52%	55
2023 Q4	$209K	Buy	+2,335	New	+$173K	0.54%	53
2023 Q3	–	Sell	-4,670	Closed	-$391K	–	64
2023 Q2	$391K	Buy	+4,670	New	+$391K	0.46%	47
2022 Q2	–	Sell	-2,335	Closed	-$261K	–	49
2022 Q1	$261K	Hold	2,335	–	–	0.68%	36
2021 Q4	$210K	Buy	+2,335	New	+$282K	0.56%	47

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Continental Investors Services's XBI Position: Q2 2026 in Review

Continental Investors Services increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.09% in Q2 2026, buying an estimated $270 and bringing the position to 2,318 shares worth $355K. The position accounts for 0.28% of the portfolio, ranked #58.

Continental Investors Services first reported a position in XBI in Q4 2021 and has held it in 12 quarters since. The position peaked at $391K in Q2 2023. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Continental Investors Services held 2,318 shares of State Street SPDR S&P Biotech ETF worth $355K as of Q2 2026.
Continental Investors Services bought 2 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $270.
State Street SPDR S&P Biotech ETF made up 0.28% of Continental Investors Services's portfolio in Q2 2026, its #58 holding.
Continental Investors Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 12 quarters since.
Continental Investors Services's State Street SPDR S&P Biotech ETF position peaked at $391K in Q2 2023.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Continental Investors Services's 13F filing for Q2 2026, filed 13 Aug 2026.